1979
DOI: 10.1172/jci109351
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of hepatic transport of bile salt. Effect of protein synthesis inhibition on excretion of bile salts and their binding to liver surface membrane fractions.

Abstract: The overall transport ofbile salts across the hepatocyte is characterized as a carrier-mediated process whose rate-limiting step is biliary secretion. Specific bile salt binding proteins have been identified in liver surface membrane fractions and were postulated to represent the initial interaction in bile salt translocation across both the sinusoidal and canalicular membranes. To test this hypothesis, cycloheximide was administered to rats to inhibit hepatic protein synthesis. 16

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

1980
1980
1995
1995

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(15 citation statements)
references
References 55 publications
0
15
0
Order By: Relevance
“…Ethinyl estradiol treatment significantly reduced Na+-K+-ATPase activity (54%), BSIBF (67%), and bile salt Tm (56%), whereas Triton WR-1339 returned these parameters to control levels (Table V). Cycloheximide administration did not prevent Triton WR-1339 reversal of either Na+-K+-ATPase activity or BSIBF in the ethinyl estradiol-treated rat, although the dose employed (150 ug/100 g body wt) has previously been shown to inhibit protein synthesis and decrease bile acid Tm, as well as prevent phenobarbital induction of Na+-K+-ATPase and bile flow (16,25).…”
Section: Resultsmentioning
confidence: 84%
See 2 more Smart Citations
“…Ethinyl estradiol treatment significantly reduced Na+-K+-ATPase activity (54%), BSIBF (67%), and bile salt Tm (56%), whereas Triton WR-1339 returned these parameters to control levels (Table V). Cycloheximide administration did not prevent Triton WR-1339 reversal of either Na+-K+-ATPase activity or BSIBF in the ethinyl estradiol-treated rat, although the dose employed (150 ug/100 g body wt) has previously been shown to inhibit protein synthesis and decrease bile acid Tm, as well as prevent phenobarbital induction of Na+-K+-ATPase and bile flow (16,25).…”
Section: Resultsmentioning
confidence: 84%
“…Since in vitro binding kinetic characteristics are similar to those for bile acid transport (7,13) and since a parallel decrease in transport and the number of bile acid binding sites are observed after cycloheximide administration, it has been proposed that the bile acid receptor represents the putative bile acid carrier (13,25 administered phenobarbital, a drug also known to increase Na+-K+-ATPase activity (8,16) to examine whether restoration of normal transport function may be possibly related to changes in sodium pump activity. Phenobarbital administered simultaneously with ethinyl estradiol restored basal bile flow, BSIBF, and Na+-K+-ATPase activity to values not significantly different from control (Table III).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Maximal transport capacity for bile salts and BSP was measured as previously described (14). To determine bile salt Tm, taurocholate was infused through either the subclavian or the femoral vein using a PE 50 catheter.…”
Section: Methodsmentioning
confidence: 99%
“…Several lines of evidence have suggested that bile salt carriers are important in the regulation of bile secretion: (a) bile salt receptors, whose affinity is independent of the sodium concentration, have been identified and characterized in liver surface membrane fractions (13); and (b) maximum taurocholate excretion rates decrease as the number of bile salt receptors decreases (14). In addition to the number of bile salt carriers, membrane lipid composition and fluidity are also major determinants of bile salt excretion (15,16).…”
Section: Introductionmentioning
confidence: 99%